| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |